Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab: Post hoc exploratory analyses of a phase II clinical trial.

被引：0

作者：

Migden, Michael Robert

Rischin, Danny

Sasane, Medha

Mastey, Vera

Pavlick, Anna

Schmults, Chrysalyne D.

Chen, Zhen

Guminski, Alexander David

Hauschild, Axel

Bury, Denise

Chang, Anne Lynn S.

Rabinowits, Guilherme

Ibrahim, Sherrif F.

Lowy, Israel

Fury, Matthew G.

Li, Siyu

Chen, Chieh-I

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA

[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[4] Sanofi, Bridgewater, NJ USA

[5] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[6] NYU, Langone Med Ctr, Dept Med Oncol, New York, NY USA

[7] Harvard Med Sch, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA

[8] Royal North Shore Hosp, Dept Med Oncol, St Leonards, NSW, Australia

[9] Univ Hosp UKSH, Dept Dermatol, Kiel, Germany

[10] Sanofi, Cambridge, MA USA

[11] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA USA

[12] Baptist Hlth South Florida, Miami Canc Inst, Dept Hematol Oncol, Miami, FL USA

[13] Rochester Med Ctr, Dept Dermatol, Rochester, NY USA

[14] Regeneron Pharmaceut Inc, Basking Ridge, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

10033

引用

页数：2